Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Severn Trent (SVT) by Bank of America
- Buy Smith & Nephew (SN.) by Edward Sheldon in The Motley Fool
- Buy Diageo (DGE) by Edward Sheldon in The Motley Fool
- Buy Ocado Group (OCDO) by Edward Sheldon in The Motley Fool
- Buy National Grid (NG.) by James Beard in The Motley Fool
- Buy Legal & General Group (LGEN) by Dr. James Fox in The Motley Fool
- Buy Hargreaves Lansdown (HL.) by Dr. James Fox in The Motley Fool
- Watch Abrdn (ABDN) by Jon Smith in The Motley Fool
- Watch Close Brothers Group (CBG) by Jon Smith in The Motley Fool
- Watch British Land Company (BLND) by Jon Smith in The Motley Fool
- Watch Primary Health Properties (PHP) by Jon Smith in The Motley Fool
- Buy Jet2 (JET2) by Phil Oakley in The Telegraph - Questor
- Hold M&G (MNG) by Deutsche Bank
- Buy PZ Cussons (PZC) by Deutsche Bank
- Outperform Kingfisher (KGF) by RBC Capital
- Outperform Watches of Switzerland Group (WOSG) by RBC Capital
- Overweight Reckitt Benckiser Group (RKT) by Barclays
- Equal Weight Relx plc (REL) by Barclays
- Hold BT Group (BT.A) by Berenberg
- Overweight Future (FUTR) by Barclays
Advanced Oncotherapy (AVO) Share Price
Health Care Sector
Members only
To view this content and much more please Sign Up
NOTE: This is based on 89 open tips for Advanced Oncotherapy (AVO)
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
01/07/2016 – Stock Consolidation 25.000:1.000
Advanced Oncotherapy (AVO) Overview
Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM. Our focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient's healthy tissues.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Advanced Oncotherapy (AVO) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Nigel Somerville | – | 2023-06-25 10:40:00 25/06/2023 | – |
| – | Nigel Somerville | – | 2023-06-01 11:50:00 01/06/2023 | – |
| – | Nigel Somerville | – | 2023-05-16 08:15:00 16/05/2023 | – |
| – | Nigel Somerville | – | 2023-02-11 10:00:00 11/02/2023 | – |
| – | Tom Winnifrith | – | 2023-01-27 08:30:00 27/01/2023 | – |
Advanced Oncotherapy (AVO) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Advanced Oncotherapy Overview
Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM. Our focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient's healthy tissues.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Advanced Oncotherapy Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Nigel Somerville | – | 2023-06-25 10:40:00 25/06/2023 | – |
| – | Nigel Somerville | – | 2023-06-01 11:50:00 01/06/2023 | – |
| – | Nigel Somerville | – | 2023-05-16 08:15:00 16/05/2023 | – |
| – | Nigel Somerville | – | 2023-02-11 10:00:00 11/02/2023 | – |
| – | Tom Winnifrith | – | 2023-01-27 08:30:00 27/01/2023 | – |
Stock Splits and Consolidations
01/07/2016 – Stock Consolidation 25.000:1.000